Suppr超能文献

相似文献

6
Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
Virology. 1995 Dec 20;214(2):642-6. doi: 10.1006/viro.1995.0078.
7
Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):947-52. doi: 10.1107/S0907444906020063. Epub 2006 Aug 19.
8
Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
Biochem Biophys Res Commun. 2006 Jun 9;344(3):1048-55. doi: 10.1016/j.bbrc.2006.03.210. Epub 2006 Apr 19.
9
A single sequence change destabilizes the influenza virus neuraminidase tetramer.
Virology. 1997 Sep 15;236(1):66-75. doi: 10.1006/viro.1997.8709.

引用本文的文献

1
Synthetic Sialosides Terminated with 8-N-Substituted Sialic Acid as Selective Substrates for Sialidases from Bacteria and Influenza Viruses.
Angew Chem Int Ed Engl. 2024 Jul 15;63(29):e202403133. doi: 10.1002/anie.202403133. Epub 2024 Jun 14.
2
Heteromultivalent Ligand Display on Reversible Self-Assembled Monolayers (rSAMs): A Fluidic Platform for Tunable Influenza Virus Recognition.
ACS Appl Mater Interfaces. 2024 Jan 24;16(3):3139-3146. doi: 10.1021/acsami.3c15699. Epub 2024 Jan 10.
3
Antiviral Approaches against Influenza Virus.
Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16.
4
Sialosides Containing 7--Acetyl Sialic Acid Are Selective Substrates for Neuraminidases from Influenza A Viruses.
ACS Infect Dis. 2023 Jan 13;9(1):33-41. doi: 10.1021/acsinfecdis.2c00502. Epub 2022 Dec 1.
5
Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors.
ACS Med Chem Lett. 2020 Aug 24;11(9):1745-1750. doi: 10.1021/acsmedchemlett.0c00313. eCollection 2020 Sep 10.
7
Antivirals Targeting the Neuraminidase.
Cold Spring Harb Perspect Med. 2022 Jan 4;12(1):a038455. doi: 10.1101/cshperspect.a038455.
8
Development of effective anti-influenza drugs: congeners and conjugates - a review.
J Biomed Sci. 2019 Oct 23;26(1):84. doi: 10.1186/s12929-019-0567-0.
9
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
Sci Rep. 2017 Sep 26;7(1):12336. doi: 10.1038/s41598-017-12101-3.
10
Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
J Infect Dis. 2017 Sep 15;216(suppl_4):S566-S574. doi: 10.1093/infdis/jiw625.

本文引用的文献

1
Rational design of potent sialidase-based inhibitors of influenza virus replication.
Nature. 1993 Jun 3;363(6428):418-23. doi: 10.1038/363418a0.
3
Slow-binding inhibition of sialidase from influenza virus.
Biochem Mol Biol Int. 1994 Apr;32(5):851-8.
6
Influenza virus neuraminidase with hemagglutinin activity.
Virology. 1984 Sep;137(2):314-23. doi: 10.1016/0042-6822(84)90223-x.
7
Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A.
J Mol Biol. 1988 Mar 5;200(1):201-3. doi: 10.1016/0022-2836(88)90344-0.
8
Three-dimensional structures of influenza virus neuraminidase-antibody complexes.
Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):511-8. doi: 10.1098/rstb.1989.0028.
10
MOPAC: a semiempirical molecular orbital program.
J Comput Aided Mol Des. 1990 Mar;4(1):1-105. doi: 10.1007/BF00128336.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验